Author:
Lee Min-Kang,Chen I-Hui,Hsu I-Ling,Tsai Wan-Hua,Lee Tzong-Yi,Jhong Jhih-Hua,Liu Bai-Chia,Huang Tsui-Yin,Lin Fang-Kuei,Chang Wen-Wei,Wu Ju-Hui
Abstract
Abstract
Background
This study examines the oral health benefits of heat-killed Lacticaseibacillus paracasei GMNL-143, particularly its potential in oral microbiota alterations and gingivitis improvement.
Methods
We assessed GMNL-143’s in vitro interactions with oral pathogens and its ability to prevent pathogen adherence to gingival cells. A randomized, double-blind, crossover clinical trial was performed on gingivitis patients using GMNL-143 toothpaste or placebo for four weeks, followed by a crossover after a washout.
Results
GMNL-143 showed coaggregation with oral pathogens in vitro, linked to its surface layer protein. In patients, GMNL-143 toothpaste lowered the gingival index and reduced Streptococcus mutans in crevicular fluid. A positive relationship was found between Aggregatibacter actinomycetemcomitans and gingival index changes, and a negative one between Campylobacter and gingival index changes in plaque.
Conclusion
GMNL-143 toothpaste may shift oral bacterial composition towards a healthier state, suggesting its potential in managing mild to moderate gingivitis.
Trial registration
ID NCT04190485 (https://clinicaltrials.gov/); 09/12/2019, retrospective registration.
Funder
GenMont Biotech Incorporation
Publisher
Springer Science and Business Media LLC